AED Efficacy from Pivotal Trials
Epilepsy/Seizure Drugs in Development
Staccato® alprazolam
Vigadrone (Vigabatrin)
500 mg/packet. ANDA of Aucta Pharmaceuticals LLC marketed by Upsher-Smith Laboratories.
Libervant (DBSF)
Aquestive
- Home
- Search
- Acute Migraine Treatment (status migrainosus), Triptans, NSAIDs
- Preventative Migraine Treatments
- NSAID
- CGRP Antibodies and Gepants
- Headache Types
- Emergency Department Treatment
- Tension Type Headache
- Indomethacin Responsive Headaches
- Children and Adolescents
- Medication Overuse Headache
- IV Infusion Protocols
- Posttraumatic Headache
- Migraine Mimics
- High and Low Pressure Headache
- Devices
- Lawrence Robbins: Advanced Headache Therapy
- Hemiplegic Migraine
- Cluster Headache Treatment
- Headache Tracking
- Sleep
- Triggers/Caffeine
- Depression Screening PHQ-2 and PHQ-9
- Publications
- Menstruation, Pregnancy and Breastfeeding
- Hormonal Therapies: Menopause and OCPs
- Butterbur
- Prodrome and Aura
- Tinnitus
- Behavioral Therapy
- Exercise
- Magnesium, Nutritional Supplements and Alternative
- Hypertension Guidlines
- MIDAS (Migraine Disability Assessment) and ASC-12
- Botox
- Vestibular Migraine
- Nerve Blocks
- Cannabinoids
- Deprescribing/ Withdrawing Medications
- Epilepsy/Seizure Drugs in Development
- Occipital Epilepsy
- Chronic Pain / Back Pain
- HIT-6 Headache Impact Test
- Thunderclap Headache
- Cerebral Vascular Anatomy
- Restaurants, Attractions & Hikes
- Referrals
- Nonpharmacological Measures